Searched for
ESRD
Public-private projects key to expand access to Kidney care: NephroPlusNephroPlus, India's leading provider of dialysis services, is on a mission to reshape the future of kidney health with an innovative tech-b...- Medicare to roll back at-home telehealth January 2026 — what coverage ends, who qualifies, and how seniors can prepare nowMedicare will end broad at‑home telehealth coverage starting January 31, 2026. Millions of seniors rely on virtual visits for routine care....
- Lords Mark Industries Ltd.–Renalyx approved to manufacture Class C AI-based haemodialysis machines; earns global CE markingLords Mark Industries Ltd. has achieved a significant feat by securing a CDSCO license to produce Class C AI-based smart haemodialysis mach...
- NephroPlus gets Sebi nod to launch IPO, to raise Rs 353 crore from fresh issueDialysis services leader Nephrocare Health Services, operating under NephroPlus, has received Sebi’s approval to launch its IPO, comprising...
- DCDC Health Services gets Rs 82 crore funding from British International InvestmentDCDC Health Services secured ₹82 crore from British International Investment to expand its dialysis network. The investment will fund over ...
- NCIL developing indigenous dialysis machine in collaboration with NIT SilcharNephro Care India Limited, in collaboration with NIT, Silchar, is developing an AI-enabled smart haemodialysis machine with a grant from We...
- Deepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check statusDeepak Parekh-backed Nephro Care's IPO GMP soars to 300% on allotment day. Here's how you can check status
- Nephro Care IPO opens today: Check issue size, price band, GMP and other detailsInvest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.
- NEERI-KFT, an Ayurvedic poly-herbal drug, can help damaged kidney recover: StudyThe herbal medicine extracted from plants has been found to correct oxidative.
- Natco gets USFDA nod to market renal disease drugNatco's Lanthanum Carbonate strengths are generic equivalent of Shire Development LLC's Fosrenol chewable tablets and are indicated to redu...
- Dialysis provider NephroPlus raises Rs 100 crore to open 500 centres in India, abroadThe company, currently with almost 100 dialysis centres, will use these proceeds to expand to 500 centres over the next five years.
- NephroPlus raises Rs 100 cr series-C funding from SeaLink Capital, IFC; Plans global forayThe company, currently with almost 100 dialysis centers, will use these proceeds to expand to 500 centers over the next five years.
- Are you a red meat lover? It may increase risk of kidney failureIncreasing numbers of individuals are developing chronic kidney disease, & many progress to end-stage renal disease, which requires dialysi...
- Therapy reduces chances of dialysisThe researchers discovered that adult stem cells when combined with a protein called serelaxin, could reverse scarring.
- Warren Buffett-backed DaVita HealthCare Partners completes NephroLife Care buy for Rs 200 croreDaVita with revenues of over $12 billion completed the acquisition by buying the equity stake belonging to serial entrepreneur Roy and othe...
- Fortis to start 50 stand-alone dialysis centres in 2 yearsFortis Healthcare on Thursday launched its first standalone dialysis centre in Delhi. The centres would be set up under the brand name, 'Re...
Load More
